Iron-deficiency anemia leaves roughly one in three women of reproductive age worldwide feeling chronically exhausted, short of breath, and unable to concentrate. Standard treatment is simple: daily iron tablets. But many women quit the pills because of nausea, cramping, and constipation before their hemoglobin levels fully recover. A systematic review published in May 2026 in BMJ Nutrition, Prevention & Health now suggests that a glass of guava juice, taken alongside each iron tablet, could meaningfully accelerate the rebound.
The review, led by Dini Ririn Andrias and colleagues at Universitas Airlangga in Indonesia, pooled data from 17 Indonesian studies conducted since 2000. Twelve of those studies provided quantitative hemoglobin measurements across 235 participants. Among the five trials that directly compared an iron-supplement-plus-guava-juice group against a supplement-only control, the juice group gained an average of 1.29 g/dL more hemoglobin. To put that number in clinical terms, the World Health Organization defines anemia in non-pregnant women as hemoglobin below 12 g/dL. A 1.29 g/dL boost could be the difference between remaining anemic and crossing that threshold.
“For a teenage girl who has been told she is anemic and handed a bottle of iron tablets, the experience is often discouraging,” said Dini Ririn Andrias, the review’s corresponding author, in an email exchange in June 2026. “She takes the pill, feels nauseous, and stops. If we can show her that drinking guava juice with the tablet helps her recover faster and possibly with fewer stomach problems, compliance becomes much easier.”
Why guava juice, specifically
Guava is one of the most vitamin C-dense fruits available. A single cup of the raw fruit delivers roughly 375 mg of ascorbic acid, more than four times the amount in an equivalent serving of orange juice, according to USDA nutrient data. Vitamin C matters here because it converts ferric iron, the form found in standard iron tablets and plant foods, into ferrous iron, which the gut absorbs far more efficiently. A mechanistic study published in The American Journal of Clinical Nutrition found that guava fruit consumed with a rice-based meal significantly increased non-heme iron bioavailability in adolescents, providing a plausible biological pathway for the effect the Indonesian trials observed. That study examined guava eaten with food rather than with an iron tablet on an empty stomach, so the conditions do not perfectly mirror the supplement scenario, but the underlying chemistry of vitamin C and iron conversion is the same.
That pathway also explains why the benefit showed up so quickly in some trials. One randomized experiment among menstruating adolescent girls tested daily guava-juice volumes of 200, 250, and 300 mL against a no-treatment control over just five days. The trial reported statistically significant hemoglobin differences between groups (p < 0.001). A separate quasi-experimental study recorded a mean hemoglobin rise from 11.46 to 12.58 g/dL in the treatment arm (p = 0.002), while the control arm showed no significant change (p = 0.334). Both results point in the same direction: pairing guava juice with iron tablets produced measurable hemoglobin gains in young women over short intervention windows.
Who stands to benefit most
WHO guidelines already identify menstruating women and adolescent girls as priority populations for daily iron supplementation, citing chronic menstrual blood loss as a key driver of iron-deficiency anemia. In low-resource settings where anemia prevalence remains stubbornly high, a low-cost dietary addition like guava juice could stretch the clinical value of each iron tablet without requiring higher doses. That matters because higher doses often bring the gastrointestinal side effects that drive people to stop taking their pills altogether. If guava juice can boost absorption enough to achieve equivalent hemoglobin recovery at a lower supplement dose, the practical benefit extends beyond lab values to everyday adherence.
Indonesia, where all 17 studies were conducted, is a useful test case. Guava grows abundantly across the archipelago, is inexpensive, and is already a familiar part of the diet. For public health programs that distribute iron tablets through schools and community health posts, adding a guava-juice component would require minimal infrastructure. The review’s authors argue that this kind of food-based strategy deserves serious consideration precisely because it is simple, culturally embedded, and unlikely to cause harm.
Consider a scenario representative of the study populations: a 16-year-old high school student in East Java is diagnosed with mild anemia during a routine school health screening. She is given a weekly supply of iron tablets but finds the nausea hard to tolerate. After learning about the review’s findings, a community health worker suggests she drink a glass of fresh guava juice each time she takes a tablet. Within a week, her hemoglobin reading at the next screening has climbed. Her experience, while hypothetical, mirrors the pattern seen across the pooled trial data and illustrates why researchers believe the strategy could work at scale.
Where the evidence thins out
The most important caveat is geographic. Every study in the review was conducted in Indonesia, a country where rice-based diets dominate and guava is cheap and plentiful. Whether the same effect holds in populations with different staple foods, cooking methods, fortification practices, or supplement formulations has not been tested. Researchers have not yet run comparable trials in sub-Saharan Africa, South Asia, or Latin America, regions where anemia burdens are also severe.
Study quality is another concern. Only two of the 17 studies were randomized controlled trials. The remaining 15 used quasi-experimental designs, which are more vulnerable to confounding. The total pooled sample of 235 participants is modest by clinical nutrition standards, and most interventions lasted just five to seven days. No study in the review tracked whether hemoglobin gains persisted after participants stopped drinking the juice. The question of whether guava juice produces durable anemia resolution, rather than a short-lived hemoglobin bump, remains unanswered.
There are also practical unknowns. Commercially processed guava juice may contain added sugar or be diluted enough to reduce its vitamin C content. The review did not compare guava juice against other vitamin C sources, such as citrus juice or a standalone vitamin C tablet taken with iron. Without those head-to-head comparisons, it is unclear whether guava offers a unique advantage or simply serves as one of many effective vitamin C vehicles. Optimal timing, whether the juice should be consumed on an empty stomach with the supplement or alongside a meal, was not systematically explored either.
What this means for people taking iron tablets now
For anyone already prescribed iron supplements, the takeaway is cautiously encouraging. The biological mechanism is well established: vitamin C enhances non-heme iron absorption. Guava juice happens to be an unusually potent source of that vitamin. The Indonesian data, while limited in scope, consistently show hemoglobin improvements when the two are combined. Discussing the option with a doctor or dietitian is reasonable, especially for women and adolescent girls who have struggled with slow recovery or supplement side effects. The key is to choose juice without excessive added sugar and to take it at the same time as the iron tablet.
For clinicians and public health planners, the most defensible next step is pilot testing. Programs that already distribute iron tablets to high-risk populations could layer in a guava-juice component and track hemoglobin, adherence, side effects, and costs over longer periods. Rigorous randomized trials outside Indonesia would go a long way toward determining whether this is a broadly applicable strategy or one that works best in specific dietary and agricultural contexts.
Why the next round of trials needs to leave Indonesia
The review does not rewrite global anemia guidelines. It does, however, highlight how a single, affordable fruit could sharpen the impact of a supplement that millions of women already take. Whether guava juice ultimately earns a formal place in iron-supplementation protocols will depend on larger, longer, and more geographically diverse trials. For now, the signal is strong enough to warrant both attention and further investment.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
